Radiologix elects director, CEO steps down:
This article was originally published in Clinica
Executive Summary
Diagnostic imaging service provider Radiologix has elected John Gunn to its board of directors. Mr Gunn has served as executive vice-president and COO of Memorial Sloan-Kettering Cancer Center in New York since 1987. The Dallas, Texas-based firm has also announced the resignation of CEO and director Stephen Linehan. Radiologix's chairman of the board, Marvin Cadwell, will serve as interim CEO until a successor is found.
You may also be interested in...
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.